M. Fiscella et al., MUTATION OF THE SERINE 15 PHOSPHORYLATION SITE OF HUMAN P53 REDUCES THE ABILITY OF P53 TO INHIBIT CELL-CYCLE PROGRESSION, Oncogene, 8(6), 1993, pp. 1519-1528
Overexpression of wild-type p53 prevents cells from entering the S pha
se of the cell cycle. The amino-terminal transactivation region of p53
is phosphorylated by several protein kinases, including DNA-PK, a nuc
lear serine/threonine protein kinase that in vitro requires DNA for ac
tivity. DNA-PK was recently shown to phosphorylate serines 15 and 37 o
f human p53 (Lees-Miller et al, 1992. Mol. Cell. Biol., 12, 5041-5049)
. To prevent phosphorylation at these sites, mutants were constructed
that changed the codons for serine 15 or serine 37 to alanine codons.
Expression of p53-Ala-37 in stably transformed T98G cells blocked prog
ression of the cells into S phase as well as did the expression of wil
d-type p53. In contrast, p53-Ala-15 was partially defective in blockin
g cell cycle progression. Several cell clones transformed with the mut
ant p53-Ala-15 gene expressed normal levels of p53 mRNA but accumulate
d little or no detectable p53 protein. However, by using a transient e
xpression system driven by a strong cytomegalovirus promoter, we showe
d that the inability of p53-Ala-15 to fully block cell cycle progressi
on was not due to inadequate levels of expression or to a failure of t
he mutant protein to accumulate in the nucleus. These results suggest
that phosphorylation of Ser-15 may affect p53 function.